These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience. Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564 [TBL] [Abstract][Full Text] [Related]
28. Rhino-orbital mucormycosis in a patient with acquired immunodeficiency syndrome (AIDS) and neutropenia. Hejny C; Kerrison JB; Newman NJ; Stone CM Am J Ophthalmol; 2001 Jul; 132(1):111-2. PubMed ID: 11438066 [TBL] [Abstract][Full Text] [Related]
31. Serous retinal detachment in a patient with rhino-orbital mucormycosis. Kim IT; Shim JY; Jung BY Jpn J Ophthalmol; 2001; 45(3):301-4. PubMed ID: 11369382 [TBL] [Abstract][Full Text] [Related]
32. Role of local amphotericin B therapy for sino-orbital fungal infections. Seiff SR; Choo PH; Carter SR Ophthalmic Plast Reconstr Surg; 1999 Jan; 15(1):28-31. PubMed ID: 9949426 [TBL] [Abstract][Full Text] [Related]
33. Rhino-orbito-cerebral mucormycosis in an immunocompetent patient: case report and review of literature. Shatriah I; Mohd-Amin N; Tuan-Jaafar TN; Khanna RK; Yunus R; Madhavan M Middle East Afr J Ophthalmol; 2012; 19(2):258-61. PubMed ID: 22623872 [TBL] [Abstract][Full Text] [Related]
34. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients. Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124 [TBL] [Abstract][Full Text] [Related]
36. [Rhino-orbito-cerebral mucormycosis in the diabetic: a better known pathology in Tunisia]. Anane S; Kaouech E; Belhadj S; Ammari L; Abdelmalek R; Ben Chaabane T; Ben Lakhal S; Cherif A; Ammamou M; Ben Fadhel K; Kallel K; Chaker E Ann Biol Clin (Paris); 2009; 67(3):325-32. PubMed ID: 19411235 [TBL] [Abstract][Full Text] [Related]
38. Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable. Keshri A; Mathialagan A; Aishwarya A; Ravisankar ; Bhuskute G; Kanaujia V; Singh AK; Singh RK; Dhiman RK; Agarwal R Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):819-827. PubMed ID: 36053359 [TBL] [Abstract][Full Text] [Related]
39. An unusual complication after cataract surgery may suggest the possibility of underlying rhino-orbital mucormycosis. Gupta N Indian J Ophthalmol; 2023 Jan; 71(1):310-311. PubMed ID: 36588264 [No Abstract] [Full Text] [Related]
40. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially. Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]